Skip to main content
ADTX logo

Aditxt, Inc.

ADTXNASDAQHealthcareBiotechnology

$0.00Today:- (-)1Y −100.00%

As of Oct 22, 2026 close

Market cap
$20.17
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.00$117.84
Volume (live)
-
Avg. volume (3M)
12.43M

ADTX was delisted on Oct 24, 2026. Data shown is historical and no longer updated.

Aditxt (ADTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Aditxt reported total assets of $16.52M and total liabilities of $12.56M. Shareholders' equity was $5.61M, down 36.8% from $8.87M a year earlier. Total debt stood at $3.01M against $3.20M in cash and short-term investments, a net cash position of $192.07K. That puts debt-to-equity at 0.54, compared with 0.78 a year earlier.

Aditxt Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Aditxt, Inc. (ADTX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents3.200.830.102.777.8710.500.000.120.03
Short-Term Investments0.00832.200.000.000.000.000.000.000.00
Cash & Short-Term Investments3.20833.030.102.777.8710.500.000.120.03
Accounts Receivable0.001.150.410.530.590.000.000.000.00
Inventory0.010.010.750.950.490.000.000.000.00
Other Current Assets0.62-832.190.220.500.460.530.000.000.00
Total Current Assets3.822.006.914.749.4211.030.000.120.03
Non-Current Assets
Property, Plant & Equipment (Net)2.082.774.105.486.361.670.000.000.00
Long-Term Investments6.6527.2822.280.000.000.000.000.000.00
Intangible Assets0.000.010.010.110.210.320.000.000.00
Other Non-Current Assets3.96-0.3111.280.410.670.070.120.000.00
Total Non-Current Assets12.7030.1437.675.997.252.060.120.000.00
Total Assets16.5232.1444.5810.7416.6613.100.120.120.03
Current Liabilities
Accounts Payable7.3410.197.521.961.580.241.851.060.01
Short-Term Debt2.666.4816.181.501.850.980.170.160.00
Current Portion of Long-Term Debt-0.150.150.410.70----
Accrued Liabilities0.353.021.03------
Deferred Revenue0.000.000.00-1.96-1.580.000.000.000.00
Other Current Liabilities2.226.730.212.151.760.010.960.430.05
Total Current Liabilities12.2223.4125.893.643.611.232.981.650.06
Non-Current Liabilities
Long-Term Debt0.340.441.041.892.880.860.000.000.00
Other Non-Current Liabilities0.000.011.600.000.000.000.000.000.03
Total Non-Current Liabilities0.340.452.641.892.880.860.001.220.03
Total Liabilities12.5623.8628.535.536.482.092.981.650.08
Stockholders' Equity
Common Stock0.000.000.000.000.040.010.000.010.01
Retained Earnings-209.81-168.09-127.74-95.04-67.35-20.88-11.73-5.90-0.21
Accumulated Other Comprehensive Income1.250.000.000.000.000.000.000.000.00
Treasury Stock0.200.200.200.200.20----
Additional Paid-in Capital214.16168.59144.00100.2477.5331.888.874.360.15
Minority Interest-1.66-0.58-0.010.000.000.000.000.000.00
Shares Outstanding0.020.000.000.000.00----
Total Stockholders' Equity5.618.8716.065.2110.1811.01-2.85-1.54-0.06
Total Liabilities & Equity16.5232.1444.5810.7416.6613.100.120.120.03

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Aditxt Balance Sheet

How much debt does Aditxt have?

Aditxt had total debt of $3.01M as of Dec 31, 2025, against $3.20M in cash and short-term investments. Its debt-to-equity ratio was 0.54. Total debt was $6.92M a year earlier.

What are Aditxt's total assets?

Aditxt reported total assets of $16.52M as of Dec 31, 2025, down 48.6% from $32.14M a year earlier. Total liabilities were $12.56M.

What is Aditxt's shareholders' equity?

Aditxt's shareholders' equity was $5.61M as of Dec 31, 2025, or about $368.09 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition